Anaphylaxis

AUVI-Q (epinephrine) 0.15mg and 0.3mg auto-injector pack

Auvi-Q Auto-Injector Approved for Anaphylaxis

Sanofi announced that the FDA has approved Auvi-Q (epinephrine injection) for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis.

Cases of Delayed Anaphylaxis to Red Meat Described

Individuals who have been bitten by the lone star tick may develop immunoglobulin E (IgE) to the carbohydrate galactose-α-1,3-galactose (alpha-gal), which puts them at risk for delayed anaphylaxis after consumption of meat containing alpha-gal on glycoproteins or glycolipids.

ARBINOXA (carbinoxamine) 4mg tablets by Hawthron Pharmaceuticals

Arbinoxa Tablets and Oral Solution Available for Allergies

Hawthorn Pharmaceuticals announced that Arbinoxa (carbinoxamine) tablets and oral solution are available for the treatment of allergic (seasonal and perennial) and vasomotor rhinitis, conjunctivitis, urticaria, angioedema, and reactions to blood.

New guidelines for food allergy

The National Institute of Allergy and Infectious Diseases (NIAID) Issues issued a new clinical practice guideline to assist healthcare professionals in the diagnosis and management of food allergy.

FDA Video: Shortage of EPINEPHrine Syringes Can Cause Errors

The American Society of Health-System Pharmacists (ASHP) and the Institute for Safe Medication Practices (ISMP) are warning that the current shortage of pre-filled EPINEPHrine emergency syringes could result in serious medication errors.

GammaGard Liquid recalled

The FDA and Baxter BioScience have notified healthcare professionals of a voluntary market withdrawal being conducted as a precautionary measure due to an increased number of adverse event reports of allergic reactions associated with two lots of GammaGard Liquid (immune globulin intravenous [human]).